The largest database of trusted experimental protocols

13 protocols using gm6001

1

Murine Lung Epithelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine lung epithelial cell line (MLE12 cells) (American Type Culture Collection, Manassas, VA, USA) was cultured in HITES medium complemented with 10% fetal bovine serum. Cells were maintained in a 37°C incubator in the presence of 5% CO2. V5 antibody was purchased from Invitrogen (Carlsbad, CA). β-actin antibody, scrambled siRNA, LPA1 siRNA, control shRNA, TrkA shRNA, batimastat (BB94), and LPA were from Sigma Aldrich (St. Louis, MO). GM6001 was from Enzo Life Science (Farmingdale, NY). Antibodies to phospho (pY674/Y675)-TrkA and Myc tag were from Cell Signaling Technology (Danvers, MA). Antibody to TrkA was from EMD MilliPore (Billerica, MA). Antibodies to phospho (p)-Erk1/2, Erk1/2, and TrkA inhibitor (TrkAi) were from Santa Cruz Biotechnology. Horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse secondary antibodies and ECL kit for detection of proteins by Western blotting was obtained from Bio-Rad Laboratories, Inc. (Hercules, CA). All other reagents were of analytical grade.
+ Open protocol
+ Expand
2

Inhibitor Studies in Podosome Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For drug inhibition studies, cells were treated with 30 µM SecinH3 (Tocris Bioscience), 10 µM Golgicide A (Santa Cruz Biotechnology, Inc.), 5 µg/ml BFA (Sigma-Aldrich), 30 µM Y-27632 (Sigma-Aldrich), 25 µM GM6001 (Enzo Life Sciences), and 2 µg/ml C3 transferase (Cytoskeleton, Inc.) in complete medium for 1–2 h or 4 h for GM6001 at 37°C with 5% CO2 and subsequently fixed with 4% PFA. For live-cell imaging, cells were imaged immediately after addition of appropriate inhibitors, which remained in the medium during the entire period of image acquisition. To study the effect of inhibitors on podosomes formed by MEFs plated on RGD lipid bilayer, the cells were treated with appropriate inhibitors 30–45 min after cell seeding on the bilayer.
+ Open protocol
+ Expand
3

Glioma Cell Culture and Hypoxia Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human D54MG, U373MG and SNB191 glioma cell lines and primary human GBM XD45 and JX10 xenolines (UAB Brain Tumor Specialized Program Of Research Excellence) were cultured in Dulbecco’s modified Eagle’s medium (Gibco-BRL, Paisley, UK) supplemented with 10% heat-inactivated fetal bovine serum, L-glutamine, penicillin/streptomycin and non-essential amino acids (all Gibco-BRL) (27 (link),28 (link)). The cells were cultured at 37°C, in a humidified atmosphere of 5% CO2 and 95% air (~21% pO2). For the hypoxia experiments, the cells were kept for the indicated durations in a cell culture incubator (I-Glove; BioSpherix, Inc., Lacona, NY, USA) with an oxygen level set to 1 or 5% pO2, as indicated. Chloroquine was purchased from Sigma-Aldrich (St. Louis, MO, USA) and the wide-spectrum MMP-inhibitor, GM6001, was obtained from Enzo Life Sciences Inc., (Farmingdale, NY, USA).
+ Open protocol
+ Expand
4

Recombinant Protein Purification Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant His‐tagged sizzled (from Xenopus laevis) was produced in 293‐EBNA cells and purified as described previously 7 (purity > 95% (SDS/PAGE), ESI‐MS m/z calcd 35481.8 found 35483.2). S33A was synthesized as described in 13 (purity > 97% (HPLC); HRMS (high‐resolution mass spectrometry; ESI (electrospray ionisation)) m/z: [MH+] calcd for C27H33N4O6S 541.2120; found 541.2119). FG‐2575 was designed and prepared by FibroGen, Inc. (purity > 95% (HPLC); MW = 503.6251; HRMS (ESI) m/z: [MH+] within 1.6 ppm of calcd value). The synthesis of the phosphinic peptide RXP‐1001 will be described elsewhere (Lecorché et al., in preparation; purity > 95% (HPLC); MS (matrix‐assisted laser desorption ionization) m/z: [MH+] calcd for C55H67N8O14P 1095.46; found 1095.57). UK383,367 and actinonin were purchased from Sigma‐Aldrich (L'isle d'abeau, France) and GM6001 from Enzo Life Sciences (Villeurbanne, France). All commercial compounds have purity > 98% (HPLC or TLC). Stock solutions of the inhibitors were prepared at 10 mm in DMSO, except for RXP‐1001 (3 mm in EtOH 50%) and sizzled (120 μm in HEPES 20 mm NaCl 0.5M pH 7.4).
+ Open protocol
+ Expand
5

Analytical Characterization of Small Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
All common solvent and reagents were obtained by commercial sources. NMR spectra were recorded on Bruker Avance III 700 MHz and these were used both for quality control and to verify the concentration of the stock solutions used for dose response measurements and in vivo studies. An Agilent LC-TOF instrument was used to obtain high-resolution mass spectral data. Purification of all agents was obtained using RP-HPLC on a JASCO preparative system equipped with a PDA detector. The instrument is also equipped with a fraction collector controlled by a ChromNAV system (JASCO). For all agents, a Luna C18 10μ 10 × 250mm (Phenomenex) column was used to purify agents to > 95% purity. For intermediate reagents that were not commercially available, RP-chromatography purification was performed using a CombiFlash (Teledyne ISCO). GM6001 was obtained from Enzo Life science. MMP408 was obtained from EMD Millipore Corp.
+ Open protocol
+ Expand
6

Cytoskeletal Protein Antibody Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cortactin (sc-30771), Tks5 (sc-30122), and Arp2 (sc-H-84) antibodies were from Santa Cruz Biotechnology. Cortactin (ab33333) was from Abcam. Anti-actin (Millipore), anti-GFP (Rockland), Rac1/3 (Upstate), specific anti-Rac3 (ProteinTech Group), and anti-Rac1 (Upstate) were also used. All Alexa Fluor–conjugated secondary antibodies were obtained from Molecular Probes (Life Technologies). GM 6001 was from Enzo Life Sciences.
+ Open protocol
+ Expand
7

Cultured Rat Hippocampal Neuron Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured hippocampal neurons were prepared from embryonic day 18 Sprague-Dawley rat brains. Dissociated neurons on poly-l-lysine coated (1 mg ml−1) coverslips were placed in neurobasal medium supplemented with B27 (Invitrogen), 0.5 mM l-glutamate and penicillin–streptomycin. For activation, cultured neurons at days in vitro (DIV) 18–21 were treated with NMDA (Sigma; 20 µM, 3 min), KCl (Sigma; 50 mM, 5 min) or l-glutamate (Sigma; 50 µM, 30 min). For induction of NMDA receptor-dependent LTD or mGluR-LTD, cultured neurons were treated with NMDA (20 µM, 3 min) and DHPG (Tocris; 50 μM, 30 min), respectively, and returned to normal conditioning medium. For the blockade of NMDA receptors, cultured neurons were pretreated with APV (Tocris; d-2-amino-5-phosphovalerate; 50 µM, 30 min), followed by stimulation with NMDA (20 µM, 3 min) in the presence of APV or with l-glutamate (50 µM, 1 min) or KCl (30 mM, 1 min) in the absence of APV. For chronic neuronal inhibition or activation, neurons were treated with tetrodotoxin (Tocris; TTX; 1 µM, 48 h) or with bicuculline (Tocris; Bic; 10 µM, 36 h). For blockade of metalloproteinase and γ-secretase activity, neurons were pretreated with GM6001 (Enzo Life Sciences; 2.5 and 25 µM, 30 min), DAPT (Sigma; 250 nM, 2 h; 2 µM, 3 h) and L-685,458 (Calbiochem; 1 µM, 30 min) before and during NMDA stimulation (20 µM, 3 min).
+ Open protocol
+ Expand
8

Tamoxifen and Estrogen Receptor Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tamoxifen (≥99%, ICI146,474, CAS: 10540-29-1) was obtained from MP Biomedicals (Santa Ana, CA). Ethylenediaminetetraacetic acid (≥99%, EDTA, CAS: 60-00-4) and 17β-estradiol (≥98%, E2, CAS: 50-28-1) were obtained from Sigma-Aldrich (St. Louis, MO). Pifithrin α hydrobromide (≥98%, CAS: 63208-82-2), SR 11302 (≥98%, CAS: 160162-42-5), and G-15 (GPER antagonist, >99%, CAS: 1161002-05-6) were obtained from Tocris Bioscience (Minneapolis, MN). GM 6001 (≥98%, CAS: 142880-36-2) was obtained from Enzo Life Sciences (Farmingdale, NY). Dimethyl sulfoxide (≥99.9%, DMSO, CAS: 67-68-5) was obtained from Avantor Performance Materials (Center Valley, PA). All chemicals stocks were prepared in DMSO.
+ Open protocol
+ Expand
9

Extracting and Quantifying Knee Collagen Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein was extracted from knee joints according to Nielsen et al (24 (link)) at week 0, 1, 2 and 4 after operation. Knee joints were isolated after euthanasia as described above, then immediately frozen in liquid nitrogen and stored at −80°C for use. The tibia and femur were cut 3 mm from the joint, producing samples weighing 500–700 mg. These samples were frozen in liquid nitrogen again, and transferred to a Bessman tissue pulverizer (Spectrum Chemical Manufacturing Corp.). The samples were crushed with 3 ml extraction buffer, consisting of 50 mM Tris-HCl buffer (pH 7.4), 0.1% Triton X-100, 0.1 M NaCl, 10 Mm (GM6001; Enzo Life Sciences, Inc.) and 1 tablet/10 ml buffer of Complete Mini EDTA-free protease inhibitor cocktail (Roche Diagnostics). Tissues were homogenized twice for 30 sec using an OMNI homogenizer (Omni International, Inc.) at speed level 4, then the samples were centrifuged for 10 min at 1,700 × g and 4°C, supernatants were obtained and centrifuged at 10,000 × g and 4°C. Finally, the supernatants were stored at −20°C until use.
Rat-specific commercially available ELISA kits (Elabscience®) were used to evaluate the levels of C-terminal telopeptide of type I collagen (CTX)-I (cat no. E-EL-R1456) and CTX–II (cat no. E-EL-R2554) in protein extracts collected from the knee, according to the manufacturer's instructions (24 (link)).
+ Open protocol
+ Expand
10

TREM2 Antibody Treatment on hiMGL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight hours after seeding the cells, they were treated with anti‐human TREM2 antibodies (Fig EV1C). Antibodies were diluted in RPMI medium and added to the cells with a final concentration of 20 µg/ml. As control for TREM2 shedding, cells were treated with GM6001 (25 µM, Enzo Life Sciences), or DMSO as a vehicle control. hiMGL were seeded in six‐well plates with 400,000 cells/well. Eight hours after seeding, antibodies were diluted in iMGL media and added at a concentration of either 20 or 40 µg/ml. Isotype or TREM2 antibodies were added at a concentration of 40 µg/ml and 24 h after antibody treatment, medium and cells were harvested as previously described.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!